Solid MNK business model will eventually attract investors, says analyst.
In a research report published Wednesday, Mizuho Securities analyst Irina Rivkind Koffler reiterated a Buy rating on shares of Mallinckrodt PLC (NYSE:MNK) with …
Apple Inc. (NASDAQ:AAPL) is in the beginning stages of developing a video sharing product.
As we head into 4Q15 earnings with the biotech sector, Nomura’s healthcare analyst Shibani Malhotra weighed in today on a handful of biotechnology stocks. Among …
Mizuho analyst Irina Rivkind Koffler weighed in today on Mallinckrodt PLC (NYSE:MNK), after the pharmaceutical company entered into a purchase agreement with The Medicines Company to …
Analysts from Mizuho Securities and Cannacord weigh in on biopharm companies Allergan PLC (NYSE:AGN) and Mallinckrodt PLC (NYSE:MNK) following Pfizer-Allergan merger deal and …
In a research report issued today, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Mallinckrodt (NYSE:MNK) with a $111 price target, which …